Cancer drug too expensive for NHS

A chemotherapy drug that extends the lives of men with advanced prostate cancer is too expensive for use on the NHS, according to draft guidance.









The National Institute for Health and Clinical Excellence (Nice) said cabazitaxel (Jevtana), in combination with prednisone or prednisolone was not cost-effective as a second line treatment after hormone therapy.



The drug has been shown to extend the lives of men with advanced prostate cancer by around 10 weeks.



Sir Andrew Dillon, chief executive of Nice, said: "When assessing the cost-effectiveness of a treatment, Nice appraisal committees will take numerous factors into account.



"These include how effective the drug is, its side effects, the effect it can have on the patient's quality of life and also the financial cost.



"This enables them to determine the cost of using the drug to provide a year of the best quality of life available or quality adjusted life year (QALY).



"Appraisal committees will normally recommend treatments that cost around £30,000 per QALY or less.



"Although cabazitaxel has been shown to be effective, it is also associated with a number of adverse events.



"The committee was particularly concerned about the uncertainty around the effect on patients' renal and cardiac systems.



"It was also concerned about the validity of the health-related quality of life information provided by the manufacturer.



"The committee also felt that the treatment did not meet the criteria to be considered under Nice's special arrangements for end of life, as based on the current data the length of the life extension could not be considered robustly proven to be at least three months.



"Once all these factors had been taken into account it was estimated that the cost per QALY would be more than £89,000.



"Therefore the committee concluded that cabazitaxel would not be a cost-effective use of limited NHS resources."



The decision is now open to consultation.



Doctors could still apply for the drug through the Government's cancer drugs fund.



Cabazitaxel is reportedly one of the drugs used to treat Lockerbie bomber Abdelbaset Ali Mohmed Al Megrahi, who is still alive two years after he was allowed to go home to Libya on compassionate grounds.



Megrahi was released from Greenock Prison after doctors advised he had around three months to live following his diagnosis for terminal prostate cancer.



Today's announcement comes after experts suggested dying cancer patients should be spared "futile" and expensive treatment which can offer "false hope" in the last weeks of life.



Warning of a tendency to "overdiagnose, overtreat, and overpromise", they said the medical profession had created a set of "unrealistic expectations" with regard to the disease.



In an article in The Lancet Oncology journal, the group said burgeoning cancer costs were being driven up by an ageing population and the rapid development of new medicines and surgery.



Led by Professor Richard Sullivan, of King's College London, they said developed countries were now heading towards a "crisis in medical care delivery".



They wrote: "Special consideration must be given to costs of cancer care at the end of life.



"Many forms of cancer are currently incurable and patients will eventually die from their disease.



"If we could accurately predict when further disease-directed therapy would be futile, we clearly would want to spare the patient the toxicity and false hope associated with such treatment, as well as the expense."



Owen Sharp, chief executive of the Prostate Cancer Charity, said: "Cabazitaxel is an important treatment, only recently licensed for use here in the UK, which can help to extend the lives of men in the final stages of prostate cancer for whom existing treatments have stopped working.



"These men currently have very few treatment options open to them when their cancer reaches this advanced stage.



"Increasing the number of treatments that may extend the lives of these men and allow them to spend precious time with their families is essential.



"We believe that every man with prostate cancer must be able to access any licensed treatment for the disease, if their doctor believes it will be beneficial.



"It is disappointing to see that Nice does not believe that cabazitaxel is a treatment it can recommend at this stage.



"It is important to remember that this announcement is not final, and that the appraisal process is still ongoing.



"We hope that further data on the difference this drug can make to the quality of life for men with advanced prostate cancer will help to strengthen the case for Nice to recommend that it be made available to men across England and Wales on the NHS.



"We hope that the drug's manufacturers are able to supply this information so that Nice can consider this new data as soon as it ready."

PA

Voices
The Sumatran tiger, endemic to the Indonesian island of Sumatra, is an endangered species
voicesJonathon Porritt: The wild tiger population is thought to have dropped by 97 per cent since 1900
News
news
Arts and Entertainment
Story line: Susanoo slays the Yamata no Orochi serpent in the Japanese version of a myth dating back 40,000 years
arts + entsApplying the theory of evolution to the world's many mythologies
Life and Style
Popular plonk: Lambrusco is selling strong
Food + drinkNaff Seventies corner-shop staple is this year's Aperol Spritz
PROMOTED VIDEO
Life and Style
ebookA wonderful selection of salads, starters and mains featuring venison, grouse and other game
News
Gardai wait for the naked man, who had gone for a skinny dip in Belfast Lough
newsTwo skinny dippers threatened with inclusion on sex offenders’ register as naturists criminalised
News
Shake down: Michelle and Barack Obama bump knuckles before an election night rally in Minnesota in 2008, the 'Washington Post' called it 'the fist bump heard round the world'
newsThe pound, a.k.a. the dap, greatly improves hygiene
Arts and Entertainment
La Roux
music
Arts and Entertainment
Graham Fellows as John Shuttleworth
comedySean O'Grady joins Graham Fellows down his local Spar
News
people
News
Ross Burden pictured in 2002
people
News
Elisabeth Murdoch: The 44-year-old said she felt a responsibility to 'stand up and be counted’'
media... says Rupert Murdoch
Arts and Entertainment
tv
Extras
indybest
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Junior / Graduate Application Support Engineer

    £26000 per annum: Ashdown Group: A highly successful international media organ...

    QA Manager - North Manchester - Nuclear & MOD - £40k+

    £35000 - £41000 per annum + competitive: Progressive Recruitment: QA Manager -...

    Property Finance Partner

    Very Competitive Salary: Austen Lloyd: LONDON - BANKING / PROPERTY FINANCE - ...

    Agile Tester

    £28000 - £30000 per annum + competitive: Progressive Recruitment: An ambitious...

    Day In a Page

    A new Russian revolution: Cracks start to appear in Putin’s Kremlin power bloc

    A new Russian revolution

    Cracks start to appear in Putin’s Kremlin power bloc
    Eugene de Kock: Apartheid’s sadistic killer that his country cannot forgive

    Apartheid’s sadistic killer that his country cannot forgive

    The debate rages in South Africa over whether Eugene de Kock should ever be released from jail
    Standing my ground: If sitting is bad for your health, what happens when you stay on your feet for a whole month?

    Standing my ground

    If sitting is bad for your health, what happens when you stay on your feet for a whole month?
    Commonwealth Games 2014: Dai Greene prays for chance to rebuild after injury agony

    Greene prays for chance to rebuild after injury agony

    Welsh hurdler was World, European and Commonwealth champion, but then the injuries crept in
    Israel-Gaza conflict: Secret report helps Israelis to hide facts

    Patrick Cockburn: Secret report helps Israel to hide facts

    The slickness of Israel's spokesmen is rooted in directions set down by pollster Frank Luntz
    The man who dared to go on holiday

    The man who dared to go on holiday

    New York's mayor has taken a vacation - in a nation that has still to enforce paid leave, it caused quite a stir, reports Rupert Cornwell
    Best comedians: How the professionals go about their funny business, from Sarah Millican to Marcus Brigstocke

    Best comedians: How the professionals go about their funny business

    For all those wanting to know how stand-ups keep standing, here are some of the best moments
    The Guest List 2014: Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks

    The Guest List 2014

    Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks
    Jokes on Hollywood: 'With comedy film audiences shrinking, it’s time to move on'

    Jokes on Hollywood

    With comedy film audiences shrinking, it’s time to move on
    It's the best of British art... but not all is on display

    It's the best of British art... but not all is on display

    Voted for by the British public, the artworks on Art Everywhere posters may be the only place where they can be seen
    Critic claims 'I was the inspiration for Blanche DuBois'

    Critic claims 'I was the inspiration for Blanche DuBois'

    Blanche Marvin reveals how Tennessee Williams used her name and an off-the-cuff remark to create an iconic character
    Sometimes it's hard to be a literary novelist

    Sometimes it's hard to be a literary novelist

    Websites offering your ebooks for nothing is only the latest disrespect the modern writer is subjected to, says DJ Taylor
    Edinburgh Fringe 2014: The comedy highlights, from Bridget Christie to Jack Dee

    Edinburgh Fringe 2014

    The comedy highlights, from Bridget Christie to Jack Dee
    Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

    Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

    The woman stepping down as chair of the Heritage Lottery Fund is worried